Public Summary Documents by Meeting
PBAC Public Summary Documents - March 2008
Public summary documents relating to the March 2008 PBAC meeting
Alendronate Sodium, tablet equivalent to 70 mg alendronic acid, Fosamax Once Weekly®, Alendronate Sodium with Colecalciferol, tablet equivalent to 70 mg alendronic acid with 70 micrograms colecalciferol, Fosamax Plus®
Bevacizumab, solution for I.V. infusion, 100 mg in 4 mL, 400 mg in 16 mL, Avastin®
Bosentan monohydrate, tablets, 62.5 mg and 125 mg (base), Tracleer®
Clopidogrel Hydrogen Sulfate, tablet 75 mg (base), Plavix®, Iscover®
Duloxetine Hydrochloride, capsules, 30 mg and 60 mg (base), Cymbalta®
Escitalopram oxalate, tablets, 10 mg and 20 mg (base) - GAD, Lexapro®
Escitalopram oxalate, tablets, 10 mg and 20 mg (base) - SAD, Lexapro®
Exenatide, pre-filled injection pen, 5 microgram per dose, 10 microgram per dose, 60 doses, Byetta®
Fludarabine phosphate, tablet 10 mg , injection 50 mg , Fludara®
Ibandronic acid, tablet, 50 mg, Bondronat®
Imatinib mesylate, tablets, 100 mg and 400 mg (base), Glivec®
Lenalidomide, capsules, 5 mg, 10 mg, 15 mg and 25 mg, Revlimid®
Lercanidipine with Enalapril, tablets, 10 mg-10 mg, 10 mg-20 mg, Zan Extra®
Levodopa with Carbidopa, intestinal gel, 20 mg–5 mg per mL, Duodopa®
Memantine hydrochloride, tablet 10 mg, and oral solution 10 mg per mL, Ebixa®
Methyl 5-aminolevulinate hydrochloride, cream, 160 mg/g, 2 g tube, Metvix®
Miglustat, capsule 100 mg, Zavesca®
Nilotinib, capsule, 200 mg, Tasigna®
Oxybutynin, transdermal patches, 36 mg (releasing approximately 3.9 mg per 24 hours), Oxytrol®
Paricalcitol, capsules, 1 microgram, 2 micrograms and 4 micrograms, Zemplar®
Pegfilgrastim, single dose pre-filled syringe, 6 mg in 0.6 mL, Neulasta®
Posaconazole, oral suspension, 40 mg per mL, 105 mL, Noxafil®
Raltegravir, tablet, 400 mg, Isentress®, March 2008
Rotigotine, transdermal patch, 4.5 mg (releasing approximately 2 mg per 24 hours), 9.0 mg (releasing approximately 4 mg per 24 hours), 13.5 mg (releasing approximately 6 mg per 24 hours), 18.0 mg (releasing approximately 8 mg per 24 hours), Neupro®
Sibutramine hydrochloride, capsules, 10 mg and 15 mg, Reductil®/Ectiva®
Sitagliptin phosphate, tablets, 100 mg, 50 mg and 25 mg, Januvia®
Somatropin, powder for injection and diluent (cartridge), 5 mg per mL, 12 mg per mL (with preservative), powder for injection and diluent (single dose syringes) in strengths from 0.6 mg – 2 mg per 0.25 mL, Genotropin® and Genotropin MiniQuick®
Sorafenib tosylate, tablet, 200 mg (base), Nexavar®
Sunitinib malate, capsules, 12.5 mg, 25 mg and 50 mg (base), Sutent® - RCC
Sunitinib malate, capsules, 12.5 mg, 25 mg and 50 mg (base), Sutent® - GIST
Tacrolimus, capsules 500 microgram, 1 mg and 5 mg, Prograf®
Tamsulosin hydrochloride, prolonged release tablet, 400 micrograms, Flomaxtra®
Telbivudine, tablet, 600 mg, Sebivo®
Zoster Virus Vaccine Live (Oka/Merk), injection, 0.65 mL, Zostavax®
